Literature DB >> 9463588

Localization of Ca(2+)-binding S100 proteins in epithelial tumours of the skin.

P Shrestha1, Y Muramatsu, W Kudeken, M Mori, Y Takai, E C Ilg, B W Schafer, C W Heizmann.   

Abstract

The Ca(2+)-binding proteins S100A1, S100A2, S100A4, S100A6 and S100B were evaluated immunohistochemically in normal skin and skin appendage tumours. Epidermal basal cells, epithelial cells of sebaceous glands, hair follicle sheet epithelia and eccrine duct reacted strongly with an antiserum against human S100A2 but were nonreactive or weakly reactive to S100A1, S100A4, S100A6 and S100B. Varying types of skin appendage tumours and most peripheral cells in tumour nests of basal cell carcinoma and squamous cell carcinoma showed positive S100A2 immunoreactivity in neoplastic cells corresponding to basal cells but were nonreactive or faintly reactive for other S100 proteins. Langerhan's cells and melanocytes were labelled by S100B. Basophilic cells of calcifying epithelioma were occasionally stained with S100A2 antiserum. Eccrine poroma did not react with any S100 antiserum. Mixed tumours of the skin containing neoplastic myoepithelial cells stained strongly for S100A2 and S100B but only faintly for S100A1, S100A4, S100A6. This is the first report on selective evaluation of different S100 proteins in normal skin. These antibodies are valuable tools for better characterization of skin appendage tumours.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9463588     DOI: 10.1007/s004280050134

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  13 in total

1.  A case of eccrine porocarcinoma: usefulness of immunostain for s-100 protein in the diagnoses of recurrent and metastatic dedifferentiated lesions.

Authors:  Yoshitaka Kurisu; Motomu Tsuji; Emi Yasuda; Yuro Shibayama
Journal:  Ann Dermatol       Date:  2013-08-13       Impact factor: 1.444

2.  Time course of differentiation of different cell types in 3D-reconstructed eccrine sweat glands.

Authors:  Mingjun Zhang; Haihong Li; Sitian Xie; Liyun Chen
Journal:  J Mol Histol       Date:  2018-09-20       Impact factor: 2.611

3.  Clinical significance of S100A2 expression in gastric cancer.

Authors:  Ying-Fu Liu; Qing-Qing Liu; Xuan Wang; Chun-Hua Luo
Journal:  Tumour Biol       Date:  2013-12-07

4.  Expression of S100A2 and S100P in human eccrine sweat glands and their application in differentiating secretory coil-like from duct-like structures in the 3D reconstituted eccrine sweat spheroids.

Authors:  Haihong Li; Mingjun Zhang; Liyun Chen; Bingna Zhang; Cuiping Zhang
Journal:  J Mol Histol       Date:  2017-03-28       Impact factor: 2.611

5.  Differential gene expression in ovarian carcinoma: identification of potential biomarkers.

Authors:  Kathleen Hibbs; Keith M Skubitz; Stefan E Pambuccian; Rachael C Casey; Kathryn M Burleson; Theodore R Oegema; Jeannine J Thiele; Suzanne M Grindle; Robin L Bliss; Amy P N Skubitz
Journal:  Am J Pathol       Date:  2004-08       Impact factor: 4.307

6.  A multimodal assessment of melanin and melanocyte activity in abnormally pigmented hypertrophic scar.

Authors:  Taryn E Travis; Pejhman Ghassemi; Jessica C Ramella-Roman; Nicholas J Prindeze; Dereck W Paul; Lauren T Moffatt; Marion H Jordan; Jeffrey W Shupp
Journal:  J Burn Care Res       Date:  2015 Jan-Feb       Impact factor: 1.845

7.  Calcium-binding S100 protein expression in pterygium.

Authors:  Andri K Riau; Tina T Wong; Roger W Beuerman; Louis Tong
Journal:  Mol Vis       Date:  2009-02-16       Impact factor: 2.367

8.  Prognostic significance of different immunohistochemical S100A2 protein expression patterns in patients with operable nonsmall cell lung carcinoma.

Authors:  Panagiotis Hountis; Periklis G Foukas; Dimitrios Matthaios; Maria Kefala; Leonidas Chelis; Aikaterini Pantelidaki; Ioannis G Panayiotides; Petros Karakitsos; Stylianos Kakolyris
Journal:  Onco Targets Ther       Date:  2012-11-21       Impact factor: 4.147

9.  S100A2 is strongly expressed in airway basal cells, preneoplastic bronchial lesions and primary non-small cell lung carcinomas.

Authors:  S L Smith; M Gugger; P Hoban; D Ratschiller; S G Watson; J K Field; D C Betticher; J Heighway
Journal:  Br J Cancer       Date:  2004-10-18       Impact factor: 7.640

10.  S100A2 is a BRCA1/p63 coregulated tumour suppressor gene with roles in the regulation of mutant p53 stability.

Authors:  N E Buckley; Z D'Costa; M Kaminska; P B Mullan
Journal:  Cell Death Dis       Date:  2014-02-20       Impact factor: 8.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.